KK
PCRX icon

KLP Kapitalforvaltning’s Pacira BioSciences PCRX Stock Holding History

KLP Kapitalforvaltning’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$753K Hold
33,300
– – ﹤0.01% 1189
2025
Q4 		$862K Sell
33,300
-14,600
-30% -$347K ﹤0.01% 1111
2025
Q3 		$1.23M Buy
47,900
+12,700
+36% +$312K ﹤0.01% 916
2025
Q2 		$841K Buy
35,200
+11,500
+49% +$290K ﹤0.01% 1076
2025
Q1 		$589K Hold
23,700
– – ﹤0.01% 1213
2024
Q4 		$447K Buy
+23,700
New +$416K ﹤0.01% 1445

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return